Ovation at Riverwalk, a 260-apartment age-restricted community to be opened in autumn 2019 near the campus of the Penn Medicine Princeton Medical Center in Plainsboro, has filled two positions. Deb Hornstra has been appointed director of community relations, and Saiqua Ferdous has been named director of customer experience.
Hornstra, a 14-year real estate professional in the Princeton area, will lead marketing, public relations and sales. She earned a bachelors degree from Syracuse University and a masters degree from Sarah Lawrence College.
In her role has director of customer experience, Ferdous will respond to inquiries and greeting visitors to the Welcome Center, slated to open mid-November in Princeton Forrestal Village. Once the community opens, she also will be responsible for communications and supervision of the concierge staff and training of the service team. Prior to joining Ovation at Riverwalk, Ferdous served in several hospitality and customer service positions at hotels in New Jersey. She earned bachelors and masters degrees from The University of Dhaka in Bangladesh.
Ovation at Riverwalk amenities will include a piano bar, pool, fitness and yoga studios, golf simulation suite, and a walking trail alongside the Millstone River.
OncoSec, 24 North Main Street, Pennington 08534. Daniel O’Connor, CEO. www.oncosec.com.
OncoSec Medical Incorporated, a company developing cancer immunotherapies, has appointed Kellie Malloy Foerter to the position of chief clinical development officer.
Foerter will be responsible for leading OncoSec’s ongoing clinical trial of a new kind of immunotherapy against late-stage melanoma that combines one of two existing immunotherapy drugs, Keytruda or Optivo, along with TAVOTM, a plasmid that is designed to make the immunotherapy treatment more effective. She will also lead a clinical trial of the same treatment against triple-negative breast cancer.
“I am delighted to welcome Kellie to the OncoSec team, as I know firsthand the rigor and creativity she brings with respect to clinical trial design, execution, and analysis,” said Daniel J. O’Connor, CEO of OncoSec.
With nearly three decades of experience in clinical research, Malloy Foerter joins OncoSec from Syneos Health, where she served as executive vice president and general manager of clinical solutions. Among her responsibilities there were oncology and hematology trials for the world’s leading biopharmaceutical companies. Earlier, she held executive positions for 20 years at inVentiv Health (previously PharmaNet), most recently serving as senior vice president of clinical research. Prior to inVentiv, she worked in research at Covance.
VolunteerConnect, Box 615, Princeton 08542. 609-921-8893. www.volunteerconnectnj.org.
Amy Klein is leaving the nonprofit group VolunteerConnect after seven years as executive director. Her last day with VolunteerConnect will be November 28.
She said the decision to leave was based on a desire to be closer to family on the West Coast. During the transition, board members will oversee management and provide guidance for specific areas within the organization. The organization said in a press release that an interim executive director will be announced in the near future.
“We will miss Amy’s leadership, vision, and her ability to make strategic connections with central New Jersey nonprofit organizations,” said Dennis Kilfeather, chairman of the VolunteerConnect board.
VolunteerConnect helps connect charities with skilled volunteers for professional services.